Prevention of Infection in Indian Neonates - Phase II Probiotics Study
Sponsor: All India Institute of Medical Sciences
A PHASE2 clinical study on Sepsis, this trial is completed. The trial is conducted by All India Institute of Medical Sciences and has accumulated 9 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Jul 2025 — Present [monthly]
Completed PHASE2
-
Sep 2024 — Jul 2025 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Mar 2022 — Jul 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Mar 2022 [monthly]
Completed PHASE2
▶ Show 4 earlier versions
-
Sep 2020 — Jan 2021 [monthly]
Completed PHASE2
-
Sep 2019 — Sep 2020 [monthly]
Completed PHASE2
-
Jun 2018 — Sep 2019 [monthly]
Completed PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2
First recorded
Jul 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- All India Institute of Medical Sciences
- Bill and Melinda Gates Foundation
- Capital Hospital, Bhubaneswar
- Department of Health and Family Welfare, Orissa
- Fogarty International Center of the National Institute of Health
- Global Network for Women's and Children's Health Research
- Ispat General Hospital, Rourkela
- Kalinga Hospital, Bhubaneswar
- NICHD Global Network for Women's and Children's Health
- National Cancer Institute (NCI)
- National Center for Complementary and Integrative Health (NCCIH)
- National Institute of Dental and Craniofacial Research (NIDCR)
- RTI International
- SCB Medical College, Cuttack
- TN Medical College, Mumbai
- University of Maryland
For direct contact, visit the study record on ClinicalTrials.gov .